1. Market Research
  2. > Healthcare
  3. > Medical Device
  4. > In Vitro Diagnostics Market Trends
  5. > United States Haematology Market Outlook to 2021

United States Haematology Market Outlook to 2021

  • August 2015
  • -
  • Global Data
  • -
  • 74 pages

United States Haematology Market Outlook to 2021

Summary

GlobalData’s new report, "United States Haematology Market Outlook to 2021", provides key market data on the United States Haematology market. The report provides value, in millions of US dollars within market segments - Haematology Analyzers, Haemostasis, Haematology Reagents, Haematology Rapid Tests & POC, Haematology Cell Counters and Immunohaematology.

The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with industry experts to validate the market size, company share and distribution share data and analysis.

Scope

- Haematology market includes Haematology Analyzers, Haemostasis, Haematology Reagents, Haematology Rapid Tests & POC, Haematology Cell Counters and Immunohaematology.
- Annualized market revenues (USD million) data for each of the market categories. Data is provided from 2007 to 2014 and forecast to 2021.
- 2014 company shares and distribution shares data for Haematology market.
- Global corporate-level profiles of key companies operating within the United States Haematology market.
- Key players covered include Danaher Corporation, Siemens Healthcare, Sysmex Corporation, Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd., Immucor, Inc., Abbott Laboratories and bioMerieux S.A..

Reasons to buy

- Develop business strategies by identifying the key market segments poised for strong growth in the future.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the market.
- Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.

Table Of Contents

United States Haematology Market Outlook to 2021
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 5
2 Introduction 6
2.1 What Is This Report About? 6
2.2 Haematology Market Segmentation 6
2.3 Definitions of Markets Covered in the Report 7
3 Haematology Market, United States 10
3.1 Haematology Market, United States, Revenue ($m), 2007-2014 10
3.2 Haematology Market, United States, Revenue ($m), 2014-2021 12
3.2.1 Haematology Cell Counters Market, United States, Revenue ($m), by Segment, 2007-2014 14
3.2.2 Haematology Rapid Tests and POC Market, United States, Revenue ($m), by Segment, 2007-2014 16
3.2.3 Haematology Reagents Market, United States, Revenue ($m), by Segment, 2007-2014 18
3.2.4 Haemostasis Market, United States, Revenue ($m), by Segment, 2007-2014 20
3.2.5 Immunohaematology Market, United States, Revenue ($m), by Segment, 2007-2014 22
3.2.6 Haematology Cell Counters Market, United States, Revenue ($m), by Segment, 2014-2021 24
3.2.7 Haematology Rapid Tests and POC Market, United States, Revenue ($m), by Segment, 2014-2021 26
3.2.8 Haematology Reagents Market, United States, Revenue ($m), by Segment, 2014-2021 28
3.2.9 Haemostasis Market, United States, Revenue ($m), by Segment, 2014-2021 30
3.2.10 Immunohaematology Market, United States, Revenue ($m), by Segment, 2014-2021 32
3.3 Haematology Market, United States, Distribution Share by Revenue ($m), 2013-2014 34
3.4 Haematology Market, United States, Company Share by Revenue ($m), 2014 35
4 Overview of Key Companies in United States, Haematology Market 37
4.1 Siemens Healthcare 37
4.1.1 Company Overview 37
4.2 Danaher Corporation 37
4.2.1 Company Overview 37
4.3 Sysmex Corporation 37
4.3.1 Company Overview 37
4.4 Bio-Rad Laboratories, Inc. 38
4.4.1 Company Overview 38
4.5 F. Hoffmann-La Roche Ltd. 38
4.5.1 Company Overview 38
4.6 Immucor, Inc. 38
4.6.1 Company Overview 38
4.7 Abbott Laboratories 39
4.7.1 Company Overview 39
4.8 bioMerieux S.A. 39
4.8.1 Company Overview 39
5 Haematology Market Pipeline Products 40
6 Financial Deals Landscape 41
6.1 Acquisition 41
6.1.1 Opko Health to Acquire Bio-Reference Labs for USD1.47 Billion 41
6.1.2 Vivione Biosciences Announces the Expiration of Agreement to Acquire Trillium Diagnostics for USD15 Million 44
6.1.3 LabCorp Acquires Covance for USD6.1 Billion 45
6.2 Debt Offerings 47
6.2.1 LabCorp Raises USD500 Million in Public Offering of 2.625% Notes Due 2020 47
6.2.2 LabCorp Raises USD500 Million in Public Offering of 3.2% Notes Due 2022 49
6.2.3 LabCorp Raises USD1 Billion in Public Offering of 3.6% Notes Due 2025 51
6.2.4 LabCorp Raises USD900 Million in Public Offering of 4.7% Notes Due 2045 53
6.3 Equity Offerings 55
6.3.1 Vermillion Raises USD18.8 Million in Public Offering of Shares 55
6.3.2 Vivione Biosciences to Raise USD8 Million in Private Placement of Shares 57
6.3.3 Vermillion Raises USD10.5 Million in Private Placement of Shares and Warrants 58
6.3.4 Venaxis Files Registration Statement to Raise USD50 Million in Public Offering of Shares 60
6.3.5 Vermillion Files Registration Statement for Private Placement of Shares for USD15 Million 61
6.4 Partnerships 62
6.4.1 Arch Therapeutics Enters into RandD Agreement with Centre for Research in Medical Devices 62
6.4.2 Vivione Biosciences Enters into Distribution Agreement with Trillium Diagnostics 63
6.4.3 NoemaLife Enters into Distribution Agreement with Horiba Medical 64
6.4.4 Abbott Labs Enters into Co-Development Agreement with US Department of Defense 65
6.5 Venture Financing 66
6.5.1 Rubicon Genomics Raises USD2 Million in Venture Financing 66
6.5.2 Magnolia Medical Technologies Raises USD6.2 Million in Venture Financing 68
6.5.3 Lucigen Raises USD2.2 Million in Venture Financing 69
6.5.4 Accriva Diagnostics Raises USD15.5 Million in Venture Financing 70
7 Appendix 71
7.1 Research Methodology 72
7.1.1 Coverage 72
7.1.2 Secondary Research 72
7.1.3 Primary Research 72
7.1.4 Company Share Analysis 73
7.1.5 Distribution Share Analysis 73
7.2 GlobalData Consulting 73
7.3 Contact Us 73
7.4 Disclaimer 74

1.1 List of Tables
Table 1: Haematology Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014 11
Table 2: Haematology Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021 13
Table 3: Haematology Cell Counters Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014 15
Table 4: Haematology Rapid Tests and POC Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014 17
Table 5: Haematology Reagents Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014 19
Table 6: Haemostasis Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014 21
Table 7: Immunohaematology Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014 23
Table 8: Haematology Cell Counters Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021 25
Table 9: Haematology Rapid Tests and POC Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021 27
Table 10: Haematology Reagents Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021 29
Table 11: Haemostasis Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021 31
Table 12: Immunohaematology Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021 33
Table 13: Haematology Market, United States, Distribution Share by Revenue ($m), USD Constant, 2013-2014 34
Table 14: Haematology Market, United States, Company Share by Revenue ($m), USD Constant, 2014 36
Table 15: Haematology Market Pipeline Products 40
Table 16: Opko Health to Acquire Bio-Reference Labs for USD1.47 Billion 41
Table 17: Vivione Biosciences Announces the Expiration of Agreement to Acquire Trillium Diagnostics for USD15 Million 44
Table 18: LabCorp Acquires Covance for USD6.1 Billion 45
Table 19: LabCorp Raises USD500 Million in Public Offering of 2.625% Notes Due 2020 47
Table 20: LabCorp Raises USD500 Million in Public Offering of 3.2% Notes Due 2022 49
Table 21: LabCorp Raises USD1 Billion in Public Offering of 3.6% Notes Due 2025 51
Table 22: LabCorp Raises USD900 Million in Public Offering of 4.7% Notes Due 2045 53
Table 23: Vermillion Raises USD18.8 Million in Public Offering of Shares 55
Table 24: Vivione Biosciences to Raise USD8 Million in Private Placement of Shares 57
Table 25: Vermillion Raises USD10.5 Million in Private Placement of Shares and Warrants 58
Table 26: Venaxis Files Registration Statement to Raise USD50 Million in Public Offering of Shares 60
Table 27: Vermillion Files Registration Statement for Private Placement of Shares for USD15 Million 61
Table 28: Arch Therapeutics Enters into RandD Agreement with Centre for Research in Medical Devices 62
Table 29: Vivione Biosciences Enters into Distribution Agreement with Trillium Diagnostics 63
Table 30: NoemaLife Enters into Distribution Agreement with Horiba Medical 64
Table 31: Abbott Labs Enters into Co-Development Agreement with US Department of Defense 65
Table 32: Rubicon Genomics Raises USD2 Million in Venture Financing 66
Table 33: Magnolia Medical Technologies Raises USD6.2 Million in Venture Financing 68
Table 34: Lucigen Raises USD2.2 Million in Venture Financing 69
Table 35: Accriva Diagnostics Raises USD15.5 Million in Venture Financing 70

1.2 List of Figures
Figure 1: Haematology Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014 10
Figure 2: Haematology Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021 12
Figure 3: Haematology Cell Counters Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014 14
Figure 4: Haematology Rapid Tests and POC Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014 16
Figure 5: Haematology Reagents Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014 18
Figure 6: Haemostasis Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014 20
Figure 7: Immunohaematology Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014 22
Figure 8: Haematology Cell Counters Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021 24
Figure 9: Haematology Rapid Tests and POC Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021 26
Figure 10: Haematology Reagents Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021 28
Figure 11: Haemostasis Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021 30
Figure 12: Immunohaematology Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021 32
Figure 13: Haematology Market, United States, Company Share (%) 2014 35

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers
2016 Competing in the Global Enteric Disease Testing Market

2016 Competing in the Global Enteric Disease Testing Market

  • $ 11500
  • Industry report
  • October 2016
  • by Venture Planning Group

Complete report $11,500.  DataPack (test volumes, sales forecasts, supplier shares) $7500. This new 389-page report from VPGMarketResearch.com contains 97 tables and provides analysis of the global enteric ...

Enteric Diseases: Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio, Yersinia

Enteric Diseases: Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio, Yersinia

  • $ 7500
  • Industry report
  • September 2016
  • by Venture Planning Group

Complete report $11,500.  DataPack (test volumes, sales forecasts, supplier shares) $7500. This new 389-page report from VPGMarketResearch.com contains 97 tables and provides analysis of the global enteric ...

World Enteric Diseases Diagnostic Testing Market Future Horizons and Growth Strategies: Supplier Shares by Test, Country Segment Forecasts, Competitive Intelligence, Emerging Opportunities

World Enteric Diseases Diagnostic Testing Market Future Horizons and Growth Strategies: Supplier Shares by Test, Country Segment Forecasts, Competitive Intelligence, Emerging Opportunities

  • $ 7500
  • Industry report
  • August 2016
  • by Venture Planning Group

Complete report $11,500.  DataPack (test volumes, sales forecasts, supplier shares) $7500. This new 389-page report from VPGMarketResearch.com contains 97 tables and provides analysis of the global enteric ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.